Skip to main content
. 2019 May 24;20(10):2564. doi: 10.3390/ijms20102564

Figure 1.

Figure 1

Biodistribution results and organ-to-blood ratios of 89Zr-DFO-9E7.4, 89Zr-oxalate in tumor-bearing mice. Ex vivo biodistribution results (A) and organ-to-blood ratios (B) of 89Zr-DFO-9E7.4 at 24 h and 72 h post-injection (PI), in the subcutaneous tumor model (n = 3 for each group). Ex vivo biodistribution results (C) and organ-to-blood ratios (D) of 89Zr-oxalate at 24 h PI (n = 3). Values are expressed in percentage of the injected radioactive dose per gram of tissue (%ID/g) and presented as mean ± SD.